MS

Matthew G. Stanton

ST Sirna Therapeutics: 6 patents #1 of 46Top 3%
MO Modernatx: 1 patents #15 of 24Top 65%
ST Sima Therapeutics: 1 patents #1 of 3Top 35%
📍 Cambridge, MA: #28 of 1,308 inventorsTop 3%
🗺 Massachusetts: #207 of 13,044 inventorsTop 2%
Overall (2017): #11,159 of 506,227Top 3%
8
Patents 2017

Issued Patents 2017

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
9850491 RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Duncan Brown, James J. Cunningham, Marian Gindy, Victoria Pickering, Steven M. Stirdivant +1 more 2017-12-26
9796977 Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery Gregory L. Beutner 2017-10-24
9751925 Alternative nucleic acid molecules containing reduced uracil content and uses thereof Stephen Hoge, William Issa, Edward J. Miracco, Jennifer Nelson, John Reynders 2017-09-05
9670487 Cationic lipids for oligonucleotide delivery Steven L. Colletti, Zhengwu J. Deng, Weimin Wang, Ivory D. Hills 2017-06-06
9669097 Low molecular weight cationic lipids for oligonucleotide delivery Brian W. Budzik, Gregory L. Beutner, Hongbiao Liao 2017-06-06
9643916 Low molecular weight cationic lipids for oligonucleotide delivery Brian W. Budzik, Steven L. Colletti, Jennifer R. Davis, Ivory D. Hills, Darla Danile Seifried 2017-05-09
9642804 Cationic lipids with various head groups for oligonucleotide delivery Mark Steven Cameron, Jennifer R. Davis, Andrea Renee GEISER, Vladislav V. Telyatnikov, Lu Tian +1 more 2017-05-09
9604908 Diether based biodegradable cationic lipids for siRNA delivery Brian W. Budzik, Steven L. Colletti 2017-03-28